-
Programmable Transimpedance Amplifier with Integrated Bandgap Reference for Glucose Concentration Measurement
Authors:
Riyaz Ahmad,
Amit M. Joshi,
Dharmendra Boolchandani
Abstract:
For glucose electrochemical sensors, a comprehensive electronics interface is designed and constructed in 0.18 um, CMOS process technology, and 1.5 V supply voltage. This interface includes a programmable readout amplifier and bandgap reference voltage potentiostat circuit. The programmable transimpedance amplifier (PTIA), the proposed readout circuit, provides a large dynamic range and low noise.…
▽ More
For glucose electrochemical sensors, a comprehensive electronics interface is designed and constructed in 0.18 um, CMOS process technology, and 1.5 V supply voltage. This interface includes a programmable readout amplifier and bandgap reference voltage potentiostat circuit. The programmable transimpedance amplifier (PTIA), the proposed readout circuit, provides a large dynamic range and low noise. The overall transimpedance increase for the PTIA is 17.3-50.5 kohm. For an input current range of 4.2-180 uA, the PTIA response has a linear output voltage range of 0.55-1.44 V. The output rms noise value is calculated to be 5.101 Vrms, and the overall power consumption of the design is 2.33 mW. The THD percentage spans from 7.6 to 10.2 in the current range mentioned above. All bandgap reference voltage potentiostat measurements are made using the reference potential of 0.6 V. The working electrode was a glassy carbon electrode (GCE) loaded with a CuO/Cu0:76CO2:25O4 (copper cobaltite) coating. An electrochemical glucose sensing setup has been used to measure glucose concentrations between 1 and 10 mM, and an emulated circuit has been used to verify the viability of the proposed glucose sensing design. The suggested glucose sensor architecture has a total size of 0.0684 mm2.
△ Less
Submitted 21 May, 2023;
originally announced May 2023.
-
Novel EEG based Schizophrenia Detection with IoMT Framework for Smart Healthcare
Authors:
Geetanjali Sharma,
Amit M. Joshi
Abstract:
In the field of neuroscience, Brain activity analysis is always considered as an important area. Schizophrenia(Sz) is a brain disorder that severely affects the thinking, behaviour, and feelings of people all around the world. Electroencephalography (EEG) is proved to be an efficient biomarker in Sz detection. EEG is a non-linear time-seriesi signal and utilizing it for investigation is rather cru…
▽ More
In the field of neuroscience, Brain activity analysis is always considered as an important area. Schizophrenia(Sz) is a brain disorder that severely affects the thinking, behaviour, and feelings of people all around the world. Electroencephalography (EEG) is proved to be an efficient biomarker in Sz detection. EEG is a non-linear time-seriesi signal and utilizing it for investigation is rather crucial due to its non-linear structure. This paper aims to improve the performance of EEG based Sz detection using a deep learning approach. A novel hybrid deep learning model known as SzHNN (Schizophrenia Hybrid Neural Network), a combination of Convolutional Neural Networks (CNN) and Long Short-Term Memory (LSTM) has been proposed. CNN network is used for local feature extraction and LSTM has been utilized for classification. The proposed model has been compared with CNN only, LSTM only, and machine learning-based models. All the models have been evaluated on two different datasets wherein Dataset 1 consists of 19 subjects and Dataset 2 consists of 16 subjects. Several experiments have been conducted for the same using various parametric settings on different frequency bands and using different sets of electrodes on the scalp. Based on all the experiments, it is evident that the proposed hybrid model (SzHNN) provides the highest classification accuracy of 99.9% in comparison to other existing models. The proposed model overcomes the influence of different frequency bands and even showed a much better accuracy of 91% with only 5 electrodes. The proposed model is also evaluated on the Internet of Medical Things (IoMT) framework for smart healthcare and remote monitoring applications.
△ Less
Submitted 19 November, 2021;
originally announced November 2021.
-
Novel Time Domain Based Upper-Limb Prosthesis Control using Incremental Learning Approach
Authors:
Sidharth Pancholi,
Amit M. Joshi Deepak Joshi,
Bradly S. Duerstock
Abstract:
The upper limb of the body is a vital for various kind of activities for human. The complete or partial loss of the upper limb would lead to a significant impact on daily activities of the amputees. EMG carries important information of human physique which helps to decode the various functionalities of human arm. EMG signal based bionics and prosthesis have gained huge research attention over the…
▽ More
The upper limb of the body is a vital for various kind of activities for human. The complete or partial loss of the upper limb would lead to a significant impact on daily activities of the amputees. EMG carries important information of human physique which helps to decode the various functionalities of human arm. EMG signal based bionics and prosthesis have gained huge research attention over the past decade. Conventional EMG-PR based prosthesis struggles to give accurate performance due to off-line training used and incapability to compensate for electrode position shift and change in arm position. This work proposes online training and incremental learning based system for upper limb prosthetic application. This system consists of ADS1298 as AFE (analog front end) and a 32 bit arm cortex-m4 processor for DSP (digital signal processing). The system has been tested for both intact and amputated subjects. Time derivative moment based features have been implemented and utilized for effective pattern classification. Initially, system have been trained for four classes using the on-line training process later on the number of classes have been incremented on user demand till eleven, and system performance has been evaluated. The system yielded a completion rate of 100% for healthy and amputated subjects when four motions have been considered. Further 94.33% and 92% completion rate have been showcased by the system when the number of classes increased to eleven for healthy and amputees respectively. The motion efficacy test is also evaluated for all the subjects. The highest efficacy rate of 91.23% and 88.64% are observed for intact and amputated subjects respectively.
△ Less
Submitted 13 January, 2024; v1 submitted 25 August, 2021;
originally announced September 2021.
-
Classification of Upper Arm Movements from EEG signals using Machine Learning with ICA Analysis
Authors:
Pranali Kokate,
Sidharth Pancholi,
Amit M. Joshi
Abstract:
The Brain-Computer Interface system is a profoundly developing area of experimentation for Motor activities which plays vital role in decoding cognitive activities. Classification of Cognitive-Motor Imagery activities from EEG signals is a critical task. Hence proposed a unique algorithm for classifying left/right-hand movements by utilizing Multi-layer Perceptron Neural Network. Handcrafted stati…
▽ More
The Brain-Computer Interface system is a profoundly developing area of experimentation for Motor activities which plays vital role in decoding cognitive activities. Classification of Cognitive-Motor Imagery activities from EEG signals is a critical task. Hence proposed a unique algorithm for classifying left/right-hand movements by utilizing Multi-layer Perceptron Neural Network. Handcrafted statistical Time domain and Power spectral density frequency domain features were extracted and obtained a combined accuracy of 96.02%. Results were compared with the deep learning framework. In addition to accuracy, Precision, F1-Score, and recall was considered as the performance metrics. The intervention of unwanted signals contaminates the EEG signals which influence the performance of the algorithm. Therefore, a novel approach was approached to remove the artifacts using Independent Components Analysis which boosted the performance. Following the selection of appropriate feature vectors that provided acceptable accuracy. The same method was used on all nine subjects. As a result, intra-subject accuracy was obtained for 9 subjects 94.72%. The results show that the proposed approach would be useful to classify the upper limb movements accurately.
△ Less
Submitted 18 July, 2021;
originally announced July 2021.
-
A Robust and Accurate Deep Learning based Pattern Recognition Framework for Upper Limb Prosthesis using sEMG
Authors:
Sidharth Pancholi,
Amit M. Joshi,
Deepak Joshi
Abstract:
In EMG based pattern recognition (EMG-PR), deep learning-based techniques have become more prominent for their self-regulating capability to extract discriminant features from large data-sets. Moreover, the performance of traditional machine learning-based methods show limitation to categorize over a certain number of classes and degrades over a period of time. In this paper, an accurate, robust,…
▽ More
In EMG based pattern recognition (EMG-PR), deep learning-based techniques have become more prominent for their self-regulating capability to extract discriminant features from large data-sets. Moreover, the performance of traditional machine learning-based methods show limitation to categorize over a certain number of classes and degrades over a period of time. In this paper, an accurate, robust, and fast convolutional neural network-based framework for EMG pattern identification is presented. To assess the performance of the proposed system, five publicly available and benchmark data-sets of upper limb activities were used. This data-set contains 49 to 52 upper limb motions (NinaPro DB1, NinaPro DB2, and NinaPro DB3), Data with force variation, and data with arm position variation for intact and amputated subjects. The classification accuracies of 91.11% (53 classes), 89.45% (49 classes), 81.67% (49 classes of amputees), 95.67% (6 classes with force variation), and 99.11% (8 classes with arm position variation) have been observed during the testing and validation. The performance of the proposed system is compared with the state of art techniques in the literature. The findings demonstrate that classification accuracy and time complexity have improved significantly. Keras, TensorFlow's high-level API for constructing deep learning models, was used for signal pre-processing and deep-learning-based algorithms. The suggested method was run on an Intel 3.5GHz Core i7, 7th Gen CPU with 8GB DDR4 RAM.
△ Less
Submitted 11 June, 2021; v1 submitted 4 June, 2021;
originally announced June 2021.
-
Smart Healthcare for Diabetes: A COVID-19 Perspective
Authors:
Amit M. Joshi,
Urvashi P. Shukla,
Saraju P. Mohanty
Abstract:
Diabetes is considered as an critical comorbidity linked with the latest coronavirus disease 2019 (COVID-19) which spreads through Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2). The diabetic patients have higher threat of infection from novel corona virus. Depending on the region in the globe, 20% to 50% of patients infected with COVID-19 pandemic had diabetes. The current article d…
▽ More
Diabetes is considered as an critical comorbidity linked with the latest coronavirus disease 2019 (COVID-19) which spreads through Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2). The diabetic patients have higher threat of infection from novel corona virus. Depending on the region in the globe, 20% to 50% of patients infected with COVID-19 pandemic had diabetes. The current article discussed the risk associated with diabetic patients and also recommendation for controlling diabetes during this pandemic situation. The article also discusses the case study of COVID-19 at various regions around the globe and the preventive actions taken by various countries to control the effect from the virus. The article presents several smart healthcare solutions for the diabetes patients to have glucose insulin control for the protection against COVID-19.
△ Less
Submitted 29 July, 2020;
originally announced August 2020.
-
iGLU 2.0: A new non-invasive, accurate serum glucometer for smart healthcare
Authors:
Prateek Jain,
Amit M Joshi,
Navneet Agrawal,
Saraju Mohanty
Abstract:
To best of the authors knowledge, this article presents the first-ever non-invasive glucometer that takes into account serum glucose for high accuracy. In case of blood glucose measurement, serum glucose value has always been considered precise blood glucose value during prandial modes. Serum glucose can be measured in laboratory and more stable glucose level compare to capillary glucose. However,…
▽ More
To best of the authors knowledge, this article presents the first-ever non-invasive glucometer that takes into account serum glucose for high accuracy. In case of blood glucose measurement, serum glucose value has always been considered precise blood glucose value during prandial modes. Serum glucose can be measured in laboratory and more stable glucose level compare to capillary glucose. However, this invasive approach is not convenient for frequent measurement. Sometimes, Conventional invasive blood glucose measurement may be responsible for cause of trauma and chance of blood related infections. To overcome this issue, in the current paper, we propose a novel Internet-of-Medical (IoMT) enabled glucometer for non-invasive precise serum glucose measurement. In this work, a near-infrared (NIR) spectroscopic technique has been used for glucose measurement. The novel device called iGLU 2.0 is based on optical detection and precise machine learning (ML) regression models. The optimal multiple polynomial regression and deep neural network models have been presented to analyze the precise measurement. The glucose values of serum are saved on cloud through open IoT platform for endocrinologist at remote location. To validate iGLU 2.0, Mean Absolute Relative Difference (mARD) and Average Error (AvgE) are obtained 6.07% and 6.09%, respectively from predicted blood glucose values for capillary glucose. For serum glucose, mARD and AvgE are found 4.86% and 4.88%, respectively. These results represent that the proposed non-invasive glucose measurement device is more precise for serum glucose compared to capillary glucose.
△ Less
Submitted 24 January, 2020;
originally announced January 2020.
-
iGLU 1.0: An Accurate Non-Invasive Near-Infrared Dual Short Wavelengths Spectroscopy based Glucometer for Smart Healthcare
Authors:
Prateek Jain,
Amit M. Joshi,
Saraju P. Mohanty
Abstract:
In the case of diabetes, fingertip pricking for a blood sample is inconvenient for glucose measurement. Invasive approaches like laboratory test and one-touch glucometer enhance the risk of blood-related infections. To mitigate this important issue, in the current paper, we propose a novel Internet-of-Medical-Things (IoMT) enabled edge-device for precise, non-invasive blood glucose measurement. In…
▽ More
In the case of diabetes, fingertip pricking for a blood sample is inconvenient for glucose measurement. Invasive approaches like laboratory test and one-touch glucometer enhance the risk of blood-related infections. To mitigate this important issue, in the current paper, we propose a novel Internet-of-Medical-Things (IoMT) enabled edge-device for precise, non-invasive blood glucose measurement. In this work, a near-infrared (NIR) spectroscopic technique using two wavelengths (940 nm, 1300 nm) is taken to detect the glucose molecule from human blood. The novel device called iGLU is based on NIR spectroscopy and machine learning (ML) models of high accuracy. An optimal multiple polynomial regression model and deep neural network (DNN) model have been presented for precise measurement. The proposed device is validated and blood glucose values are stored on the cloud using open IoT platform for remote monitoring by an endocrinologist. For device validation, the estimated blood glucose values have been compared with blood glucose values obtained from the invasive device. It has been observed that mean absolute relative difference (MARD) and average error (AvgE) are found 4.66 % and 4.61 % respectively from predicted blood glucose concentration values. The regression coefficient is found 0.81. The proposed spectroscopic non-invasive device provides accurate and cost-effective solution for smart healthcare.
△ Less
Submitted 10 November, 2019;
originally announced November 2019.
